Are somatostatin analogues (octreotide and lanreotide) effective in promoting healing of enterocutaneous fistulas?
Gray
Mikel
M
Department of Urology, School of Nursing, University of Virginia, PO Box 800422, Charlottesville, VA 22908, USA. mg5k@virginia.edu
Jacobson
Therese
T
D017577:Cutaneous Fistula / Q000188:drug therapy*; D006801:Humans; D007412:Intestinal Fistula / Q000188:drug therapy*; D015282:Octreotide / Q000494:pharmacology*; D010185:Pancreatic Fistula / Q000517:prevention & control; D010456:Peptides, Cyclic / Q000494:pharmacology*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D014945:Wound Healing / Q000187:drug effects*
D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D015282:Octreotide